ODG
ABMD

O'Dell Group’s Abiomed Inc ABMD Stock Holding History

O'Dell Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-113
Closed -$28K – 440
2022
Q3 		$28K Hold
113
– – 0.01% 193
2022
Q2 		$28K Hold
113
– – 0.01% 202
2022
Q1 		$37K Buy
+113
New +$34.8K 0.01% 205

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

O'Dell Group's ABMD Position: Q4 2022 in Review

O'Dell Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 113 shares — an estimated $28K sold.

O'Dell Group first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $37K in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • O'Dell Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • O'Dell Group sold 113 Abiomed Inc shares in Q4 2022, an estimated $28K.
  • O'Dell Group first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
  • O'Dell Group's Abiomed Inc position peaked at $37K in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on O'Dell Group's 13F filing for Q4 2022, filed 14 Feb 2023.